within Pharmacolibrary.Drugs.ATC.A;

model A10AB01
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 1.9999999999999998e-05,
    adminDuration  = 600,
    adminMass      = 0.1 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 5.9999999999999995e-05,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.00016,
    k12             = 0.5,
    k21             = 0.5
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A10AB01</td></tr><td>route:</td><td>subcutaneous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Insulin (human) is a peptide hormone used primarily in the treatment of diabetes mellitus. It replaces or supplements endogenous insulin, facilitating the uptake of glucose by tissues. Human insulin is the standard therapeutic agent for controlling blood glucose in both type 1 and type 2 diabetes, and remains approved for clinical use globally.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are reported for healthy adult subjects after subcutaneous administration.</p><h4>References</h4><ol><li><p>Nishimura, E, et al., &amp; Haahr, H (2021). Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing. <i>BMJ open diabetes research &amp; care</i> 9(1) –. DOI:<a href=\"https://doi.org/10.1136/bmjdrc-2021-002301\">10.1136/bmjdrc-2021-002301</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/34413118/\">https://pubmed.ncbi.nlm.nih.gov/34413118</a></p></li><li><p>Ma, X, et al., &amp; Leishman, D (2022). Pharmacokinetics and Pharmacodynamics of Human Regular U-500 Insulin Administered via Continuous Subcutaneous Insulin Infusion Versus Subcutaneous Injection in Adults With Type 2 Diabetes and High-Dose Insulin Requirements. <i>Journal of diabetes science and technology</i> 16(2) 401–407. DOI:<a href=\"https://doi.org/10.1177/1932296820972719\">10.1177/1932296820972719</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33242998/\">https://pubmed.ncbi.nlm.nih.gov/33242998</a></p></li><li><p>Brogden, RN, &amp; Heel, RC (1987). Human insulin. A review of its biological activity, pharmacokinetics and therapeutic use. <i>Drugs</i> 34(3) 350–371. DOI:<a href=\"https://doi.org/10.2165/00003495-198734030-00003\">10.2165/00003495-198734030-00003</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3315622/\">https://pubmed.ncbi.nlm.nih.gov/3315622</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A10AB01;
